| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $4.53B | +3.1% |
| Cost of Revenue | $1.08B | -2.1% |
| Gross Profit | $3.45B | +4.8% |
| R&D Expense | $803.2M | +3.8% |
| SG&A Expense | $579.6M | +0.6% |
| Operating Income | $525.3M | +114.0% |
| Pre-tax Income | $832.3M | +233.9% |
| Income Tax | $194.8M | +33.9% |
| Net Income | $637.5M |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.56B | +43.4% |
| Accounts Receivable | $536.1M | -3.8% |
| Current Assets | $7.93B | +24.7% |
| Total Assets | $9.93B | +22.2% |
| Current Liabilities | $1.76B | +1.4% |
| Total Liabilities | $1.91B | -0.6% |
| Stockholders' Equity | $8.02B | +29.2% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.60B | +23.9% |
| Capital Expenditures | $127.0M | +22.3% |
| Investing Cash Flow | -$1.18B | -271.9% |
| Financing Cash Flow | $60.2M | +106.4% |
| Free Cash Flow | $1.47B | +24.1% |
| +514.7% |
| EPS (Basic) | $2.12 | +505.7% |
| EPS (Diluted) | $2.07 | +508.8% |